No Picture
News

New Billboard in San Diego Highlights Lack of Legal Medical Cannabis Access for Veterans in San Diego

Advocacy group Weed for Warriors billboard campaign underscores plight of veterans struggling to access life-saving medical cannabis SAN DIEGO, Calif., May 3, 2022 /PRNewswire/ — “Restricting access to cannabis = increased opioid addiction and suicide.” […]

No Picture
News

Cellics Therapeutics Receives First IND Allowance by FDA for Its Innovative Cellular Nanoparticle (CNP) Technology

SAN DIEGO–(BUSINESS WIRE)–Cellics Therapeutics, Inc., a biotech startup company using the innovative Cellular Nanoparticle (CNP) Technology for the treatment and prevention of infectious and inflammatory diseases, announced today that the U.S. Food and Drug Administration […]

No Picture
News

Discovery Life Sciences™ Further Validates Quality of its Biospecimen Solutions by Participating in VERIF.i®, Scientist.com’s Supplier Pre-assessment Program

SAN DIEGO–(BUSINESS WIRE)– #Compli–Discovery Life Sciences participates in VERIF.i, Scientist.com’s supplier pre-assessment program Click here to view original post

No Picture
News

Lassen Therapeutics Announces Presentations on Novel IL-11 Receptor-Blocking Antibody at the American Thoracic Society 2022 Annual Meeting

SAN DIEGO–(BUSINESS WIRE)–Lassen Therapeutics, a biotech company developing breakthrough antibody therapeutics as potential treatments for fibrosis, rare diseases, and oncology, today announced upcoming presentations of new data on its novel IL-11 receptor-blocking antibody at the […]

No Picture
News

HAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies

LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)– #Innosuisse–HAYA Therapeutics announces funding from Swiss Innovation Agency supporting research collaborations for Long Non-Coding RNA Therapies Click here to view original post

No Picture
News

Locanabio to Present New Preclinical Data Demonstrating Application of CORRECTx™ Platform for Treating Amyotrophic Lateral Sclerosis at American Society of Gene and Cell Therapy 25th Annual Meeting

SAN DIEGO, May 2, 2022 /PRNewswire/ — Locanabio, Inc., a genetic medicines company developing RNA-targeted therapeutics for patients with severe neuromuscular and neurodegenerative diseases, today announced that new data from preclinical research of its proprietary […]

No Picture
News

Acadia Pharmaceuticals Announces FDA Advisory Committee Meeting to Review Resubmission of Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer’s Disease Psychosis Scheduled for June 17, 2022

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that a virtual meeting of the U.S. Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee to review the resubmitted supplemental New Drug Application (sNDA) for pimavanserin […]

No Picture
News

Fig, the food as medicine company, officially launches its revolutionary mobile app, opening a new world of food opportunity for those with dietary restrictions.

The Fig app helps you find food you CAN eat at grocery stores, regardless of how complex your dietary needs are. SAN DIEGO, May 2, 2022 /PRNewswire/ — The Fig app, the most comprehensive food […]

No Picture
News

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

Viral capture efficiency ranged from 53% to 89% for the seven COVID-19 variants tested SAN DIEGO, May 2, 2022 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to […]

No Picture
News

Helixmith Announces VM202 (Engensis®) Presentation at New York Academy of Sciences “Advances in Pain” Meeting on May 3, 2022

Dr. Jack Kessler of Northwestern University will present “New Concept for Neuropathic Pain Relief with Regenerative Medicine Potential Based on Plasmid DNA Encoding Human Hepatocyte Growth Factor, VM202: Scientific Basis and Results from Clinical Studies” […]

No Picture
News

Genome Insight Draws $23 Million in Series B Funding to Open the Whole Genome Era for Transforming Precision Medicine

SAN DIEGO–(BUSINESS WIRE)–Genome Insight, a global leader in Whole Genome Sequence analysis and interpretation, announced $23 million in Series B funding. Dunamu & Partners led the financing with participation from InterVest, Signite Partners, KC, and […]